Developments Therapix’s CannAmide approved by Health Canada Therapix Biosciences (NASDAQ:TRPX) reported that Health Canada issued a product license for CannAmide as an anti-inflammatory, and for relief of chronic pain. CannAmide is an immediate release formulation of the... July 31, 2019